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Abstract
Cognitive behavioural therapy is an effective treatment for anxiety disorders in children and young people; however, many 
do not benefit. Behavioural exposure appears to be the critical ingredient in the treatment of anxiety disorders. Research 
with adults has identified innovative strategies to optimise exposure-based treatments, yet it is not clear how to optimise the 
effects of exposure for children and young people. This review was a preliminary exploration of the association between 
potential optimisation strategies and treatment procedures and outcomes for the treatment of child anxiety symptoms/disor-
ders. We searched Psych-Info and Medline databases using a systematic search strategy and identified 29 articles. We found 
preliminary evidence that some specific strategies may enhance the effects of exposure, such as dropping safety behaviours, 
parents and therapists discouraging avoidance, and the use of homework. However, not one significant finding was replicated 
by another study for the same timepoint using the same methodology. To a large degree, this lack of replication reflects a 
limited number of studies combined with a lack of consistency across studies around conceptualisations, methodological 
approaches, and outcome measures making it difficult to make meaningful comparisons between studies and draw firm 
conclusions. Examination is needed of a wide range of theoretically-driven potential optimisation strategies using methodo-
logically robust, preclinical studies with children and young people. Furthermore, the methods used in future research must 
enable comparisons across studies and explore developmental differences in the effects of particular optimisation strategies.
Keywords Child · Adolescent · Youth · Anxiety · Exposure · Cognitive behaviour therapy
Introduction
Anxiety and related disorders1 are among the most com-
mon and impairing mental health disorders in children and 
adolescents, with worldwide prevalence rates estimated at 
6.5% (Polanczyk et al. 2015). This is of particular concern 
as, if left untreated, childhood anxiety disorders can run a 
chronic course (Bittner et al. 2007; Broeren et al. 2013), are 
associated with educational underachievement (Owens et al. 
2012), poor peer relationships (Asendorpf et al. 2008) and 
poor social (Settipani and Kendall 2013) and occupational 
(Swan and Kendall 2016) functioning.
Cognitive behavioural therapy (CBT) is typically the 
first-line treatment for child and adolescent anxiety disor-
ders (e.g. National Institute for Health and Care Excellence 
2014; World Health Organization 2015). Although CBT is 
an effective treatment, approximately 41% of young people 
do not benefit (James et al. 2015). Furthermore, a naturalistic 
follow-up study of anxious youth treated with CBT found 
that 48% of initial treatment responders relapsed following 
treatment (≤ 6 years) (Ginsburg et al. 2014). Together these 
studies emphasise that although CBT for childhood anxiety 
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1 The Diagnostic and Statistical Manual Fifth Edition (DSM-5) 
(American Psychiatric Association 2013) reclassified obsessive com-
pulsive disorder (OCD) and post-traumatic stress disorder (PTSD) 
from “anxiety disorders” to other categories. However, anxiety dis-
orders, OCD and PTSD are all characterised by clinically significant 
fear, anxiety and distress in response to stimuli and/or situational cues 
(McGuire et al. 2016). As such, these disorders have been referred to 
as ‘anxiety disorders’ from here on.
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disorders is beneficial, there is a clear need for improve-
ment. The critical ingredient in CBT for the treatment of 
anxiety disorders in children and young people appears to be 
behavioural exposure (Kendall et al. 2005; Peris et al. 2015; 
Peterman et al. 2014), a controlled therapeutic technique 
that involves the person facing an anxiety-provoking stimu-
lus or situation (Marks 1973). The theoretical foundations 
and proposed mechanisms of change that guide behavioural 
exposure have important implications for how the exposure 
session is planned, conducted and appraised (Abramowitz 
2013).
Behavioural exposure was first derived from principles 
of associative learning through fear conditioning (learn-
ing to predict an aversive event by pairing a neutral stimu-
lus with an aversive stimulus) and extinction (the gradual 
decrease in response to a conditioned fear when the stimulus 
is presented in the absence of the reinforcement) whereby 
within- and between-session fear reduction and habituation 
reflects successful learning (e.g. Emotion Processing The-
ory; Foa and McNally 1996). However, recent studies with 
adults have failed to find a significant relationship between 
within-exposure habituation and level of fear on behavioural 
avoidance tests at follow-up weeks to months later (Kircan-
ski et al. 2012b). Furthermore, research with animals has 
suggested that, rather than facilitate successful exposure, 
rapid habituation may actually impede long-term learning 
(Woods and Bouton 2008). As such, more contemporary 
accounts of exposure suggest that associations learned dur-
ing threat-conditioning (i.e. when the fear is acquired) are 
not weakened or forgotten but compete with new non-threat-
ening associations. For example, Inhibitory Learning Theory 
(Craske et al. 2008) proposes that the failure to benefit from 
exposure is due to deficits in cognitive mechanisms, includ-
ing inhibitory learning (i.e. learning which inhibits previous 
learning) (Craske et al. 2008), and the focus of inhibitory 
learning-guided exposure should be to develop new (non-
threatening) associations that overshadow the excitatory 
(threatening) association. It is therefore proposed that the 
‘success’ of exposure is reflected by effective consolidation, 
retrievability and generalisability of new inhibitory learning 
assessed during follow-up, rather than the degree of fear 
reduction that occurs between and within exposure sessions 
(Craske et al. 2014).
Inhibitory Learning Theory has highlighted several strate-
gies that enhance extinction learning and may also increase 
the effectiveness of exposure within treatment. Examples 
include violating expectancies about harm, occasional rein-
forced extinction, reducing safety seeking behaviours (Salko-
vskis et al. 2007; Sloan and Telch 2002), stimulus variability 
(Culver et al. 2012; Kircanski et al. 2012b) and affect label-
ling (Kircanski et al. 2012a; Niles et al. 2015). Furthermore, 
exposure may be optimised by pharmacological strategies to 
enhance memory consolidation. For example, D-Cycloserine 
(DCS) has been shown to have a small augmentation effect 
on exposure-based psychotherapy for adults with anxiety, 
obsessive compulsive and post-traumatic stress disorders 
(Mataix-Cols et al. 2017).
Inhibitory Learning Theory and its application to opti-
mise exposure has predominantly been based on research 
with adults and its application to younger people remains 
unclear. Indeed, most empirically tested CBT treatment 
protocols for childhood anxiety disorders apply traditional 
habituation-based models of exposure (e.g. Kendall et al. 
2002; Kendall and Hedtke 2006). However, there are indi-
cations from animal research that different biological path-
ways may underpin fear extinction in children, adolescents 
and adults (Shechner et al. 2014) and notably, among rats, 
there appears to be a unique developmental period whereby 
fear expression and extinction are temporarily impaired dur-
ing adolescence (Ganella and Kim 2014). Consistent with 
the animal work, recent findings from a threat-conditioning 
study with humans found that relative to children and adults, 
adolescents exhibited impairments during extinction where 
they were less likely to retain new, non-fearful, inhibitory 
information (Waters et al. 2017). The maturation of brain 
structures and neurotransmitter systems are likely to be 
responsible for these developmental distinctions in extinc-
tion as the human brain undergoes rapid developmental 
changes (Sowell et al. 1999). In addition to potential bio-
logical mechanisms underlying developmental differences in 
the process of fear extinction, there may be other factors that 
have an impact on the efficacy of exposure in children and 
young people. For example, parent or carer responses may 
influence the extent to which children are able to undertake 
the active parts of treatment by interacting with fearful situ-
ations or stimuli, through the degree to which they model 
and reinforce ‘brave’ approach-related behaviours and facili-
tate exposure in multiple contexts between sessions (e.g. at 
home, in school, in the community). As such it is plausible 
that the effectiveness of strategies to promote exposure may 
differ through development and that specific consideration 
of how to optimise exposure among children and adolescents 
is required.
Summary and Aim of Review
This systematic review will explore factors associated with 
differential outcomes from exposure in children and young 
people with anxiety symptoms/disorders, and where pos-
sible examine how associations differ across this age range, 
by examining:
 (i) Specific exposure optimisation strategies (e.g. phar-
macotherapy and parental involvement)
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 (ii) Specific characteristics of the process of exposure 




The review was conducted using the Preferred Reporting 
Items for Systematic Reviews and Meta-Analysis of Indi-
vidual Participant Data (Moher et al. 2009). The study pro-
tocol was registered with PROSPERO (CRD42018109875) 
and it is accessible from www.crd.york.ac.uk/PROSP ERO/
displ ay_recor d.php?Recor dID=10987 4
Search Strategy
A systematic review of the literature was conducted dur-
ing November 2019 using two databases Psych-INFO and 
Medline (Pub-Med). The start time was selected based on 
the earliest material published in the databases. The search 
used key exposure-based treatment terms: exposure in con-
junction with therapy, treatment, intervention and behavio*, 
anxiety-related terms: anxi*, worry, fear*, obsess*, com-
pul*, OCD, panic, GAD, phobi*, mute, mutism, agora*, 
PTSD, post-traumatic and (stress adj2 disorder),2 and terms 
to identify studies which involved children and adolescents: 
child, children, childhood, adolescen*, youth and teen*. The 
search results were collated in Endnote where duplicates 
between databases were removed.
Inclusion Criteria
Studies were included in the review if they met the following 
criteria via a hierarchical coding system:
 1. Written in English
 2. Peer-reviewed empirical study (case studies not 
included)
 3. Involved human participants aged between 3 and 
21 years, with a mean age of ≥ 5 and ≤ 18 years
 4. Focussed on typically developing children/adolescents
 5. Included at least one condition with a core exposure-
based intervention/treatment component (≥ 50% ses-
sions contained exposure) that targets pre-existing fear 
/ anxiety
 6. Used at least one anxiety or fear-related outcome meas-
ure
 7. Reported the statistical association between an expo-
sure strategy or characteristic and treatment outcomes:
 (i) Compared exposure with and without a particular 
strategy (“exposure plus” condition). To ensure that 
observed effects were carried by features of the expo-
sure component of an intervention/treatment (rather 
than other elements delivered as part of a wider 
treatment package, for example, psychoeducation), 
a strategy was defined as an “exposure strategy” if 
the intervention/treatment was ≥ 80% exposure OR 
if the strategy was administered during the exposure 
component of treatment (e.g. directly before, during 
or directly after an exposure session). For example, 
a study would be included if a strategy (e.g. pharma-
cotherapy) was introduced during the exposure com-
ponent of a treatment that was 50% exposure (e.g. 
Leyfer et al. 2019) but excluded if the strategy was 
introduced during other, non-exposure components 
of treatment (e.g. Compton et al. 2010).
 (ii) Reported an association between features of expo-
sure practice (i.e. specific characteristics of exposure 
which have not been experimentally manipulated 
for example; use of safety seeking behaviour dur-
ing exposure) and treatment outcome[s]. Exposure 
practice can also include between-session exposure-
related activities (e.g. parental training to support 
between-session exposure)
Study Selection
Following a search of electronic databases, the selection 
process was piloted using a sample of papers. Abstracts 
were screened for inclusion by HP and second rated by one 
of three undergraduate psychology research assistants with 
a high level of reliability (k = 0.82). Full-text articles were 
screened for inclusion by HP and second rated by a post-
graduate psychology research assistant with a substantial 
level of reliability (k = 0.73). Reference lists of the primary 
studies identified were reviewed to identify further potential 
studies of interest, and abstracts were retrieved, and full texts 
screened for inclusion, if appropriate. All queries regarding 
study eligibility were discussed and resolved between HP, 
CC and PW. The study selection process and the number of 
studies remaining at each stage is shown in Fig. 1.
Data Extraction
For each study, the following information was extracted: 
study location, sample characteristics including child age 
and anxiety diagnostic status, intervention characteristics 
including treatment protocol and exposure technique, pri-
mary outcome measure(s) and where relevant, the inclu-
sion and duration of follow-up assessment. The data was 
2 The ‘2′ is a proximity search which specifies that the search terms 
(i.e. stress and disorder) are a maximum of two words apart from one 
another, regardless of the order in which they appear.
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extracted by HP. Where there was missing data or additional 
data needed, authors of the studies were contacted.
For studies that examined the efficacy and effectiveness 
of exposure optimisation strategies, the following informa-
tion was also extracted: (i) percentage of intervention con-
taining exposure, and (ii) exposure PLUS (i.e. strategy) and 
exposure ONLY information (i.e. control). For studies that 
examined the relationship between exposure process vari-
ables and treatment outcomes, we also extracted exposure 
process variable information (e.g. safety seeking behaviour).
Outcome Measure of Fear/Anxiety
We developed a hierarchy of preferred outcome measures:
1. Clinician ratings (CSR)—i.e. independent evaluators 
used a structured diagnostic interview such as the Anxi-
ety Disorders Interview Schedule for Children – Child 
and Parent Versions (ADIS-C/P) (Silverman & Albano, 
1996) and assigned a CSR using a 0–8 scale based on 
child/parent interviews.
2. Self-report measures of symptom severity/fear—i.e. 
child/parent questionnaires.
3. Approach/avoidance of the feared situation/stimulus—
i.e. Behaviour Assessment Test (BAT).
4. Self-rating of anxiety during exposure –i.e. Subjective 
Units of Distress Scales (SUDS).
Fig. 1  Study selection
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For each study, if multiple outcomes were reported the dis-
order/fear specific outcome measure with the highest rank was 
selected for inclusion. If a study included multiple measures 
from one category, the most frequently used measure across 
all studies in the review was selected. If a study included a 
self-report measure and a BAT, both measures were reported. 
Where child and parent measures were provided separately, 
both informants’ reports were included.
Data Synthesis
Due to the heterogeneity of studies included within the review 
(e.g. participants, anxiety disorder/symptoms, primary out-
come measures, study design, exposure strategy and/or pro-
cess variable) the findings were evaluated through a narrative 
approach. Where possible, effect sizes were extracted or cal-
culated for each individual study. For within-subject studies, 
effect sizes were reported as Pearson’s product-moment cor-
relation coefficient (r). Where studies reported only standard-
ised multiple regression coefficients, rather than correlation 
coefficients, we used Peterson and Brown’s (2005) imputation 
approach to convert B coefficients to corresponding coeffi-
cients (r). For experimental studies involving group compari-
sons, effect sizes were reported as Cohen’s d. Where studies 
did not report Cohen’s d, this was calculated using the avail-
able data (Cohen 1988) for each available timepoint. Where 
no effect size is reported it is because sufficient data were 
unavailable.
Study Quality Ratings
All included studies were evaluated for methodological qual-
ity using an adapted version of Moncrieff et al. (2001)’s study 
quality assessment instrument. As this review included experi-
mental and within-subject studies, adaptations were made to 
the instrument to account for the differences in designs. For 
within-subject studies, the following standards were omitted 
from the assessment: Item (5) Method of Allocation; Item (6) 
Concealment of Randomisation; Item (8) Blinding of Subjects 
and Item (17) Information on Comparability and Adjustment 
for Differences in Analysis. One item was adapted to reflect 
the single condition nature of these types of studies: Item (15) 
Record of Number and Reason for Withdrawal (omitted ‘by 
group’). For experimental studies, all items from the original 
instrument were included. Items 8 (blinding of subjects) and 
13 (blinding of assessor) were combined. All included stud-
ies were rated by the first author (HP) and second rated by 
the third author (KG). Inter-rater reliability for study quality 
ratings was excellent (k = 0.98). All discrepancies and queries 




Twenty-nine studies were identified, published between 1993 
and 2019, details of which can be found in Tables 1 and 2. 
Seventeen (59%) of the studies used an experimental, between-
subject design and 12 (41%) used a within-subject design.
Sixteen studies (55%) included participants with a broad 
age range (e.g. 7–17 years), 6 (21%) included children and 
early adolescents (e.g. 6–14 years), 4 (14%) only included 
young children (e.g. 3–8 years) and 3 (10%) only included 
adolescents (e.g. aged 12–17 years).
Twenty-five (86%) studies included clinical samples that 
met diagnostic criteria for anxiety disorders, and all of these 
studies delivered treatment using a manualised protocol (e.g. 
Angelosante et al. 2009; Kendall and Hedtke 2006; March and 
Mulle 1998; Öst 1989, 1997). Four (14%) of the studies did not 
conduct diagnostic assessments; two used an exposure-based 
intervention (e.g. gradual in vivo exposure) and two used a 
manualised trauma-focussed treatment protocol (i.e. Cohen 
et al. 2006). Twenty-two (76%) studies used an intervention/
treatment protocol that included exposure in more than 50% of 
the sessions. However, only three (10%) studies reported the 
association between the amount of time spent on exposure/
the number of exposures and treatment outcomes. Twenty-
one (72%) studies used an intervention/treatment protocol that 
involved parents, 5 (17%) only included children/adolescents 
and 3 (10%) did not report parent involvement.
Twenty-eight (97%) of the studies included a post-exposure 
assessment, and 16 (55%) included one or more follow-up 
assessments ranging from 4 days to 1-year post-exposure.
Quality Ratings
As shown in Tables 1 and 2, quality ratings ranged widely 
from 33 to 83%. Particular areas of weakness in study quality 
related to a lack of information on and inclusion of withdraw-
als, fidelity, sample size, compliance and power calculation. 
There was also commonly a lack of information about side 
effects, although these were more commonly reported in 
studies of pharmacological approaches. Notably, only 7 stud-
ies included a follow-up > 3 months post-treatment comple-
tion and only 2 studies included a generalisation assessment 
(Table 3).
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Table 3  Differences between conditions and associations between characteristics of exposure and anxiety outcomes, by assessment timepoint
Construct Study Anxiety Type Studies (n) Effect Size by assessment 
timepoint
Cohen’s d or r
Before exposure







Pa: PT =  − 0.15
Pa: 1 m =  − 0.69□





Storch et al (2010) OCD 2 PT = -0.67 Medium d
Storch et al (2016) PT = ⋄ - -





Scheeringa and Weems 
(2014)






Same context Specific Phobia 1 1w = 0.19 Small r
Novel context 1w = -0.37* Medium r
DCS at the commencement 
of exposure









Rapee et al (2016) Mixed 1 PT = 0.56□ Medium d
Pa: PT = -0.23□ Small
Sertraline Storch et al (2013)
RegSert
OCD 2 PT = −0.02□ NE d
SlowSert PT = 0.23□ Small d
The POTS Study (2004) PT = −0.31□** Small d
Attention Training to Posi-
tive Stimuli (ATP)





Observational Learning Menzies and Clarke (1993)
Same context
Fear of Water 2 PT = ⋄
12w = ⋄*
- -













Social Skills Training Olivares-Olivares et al 
(2019)







Preparation Tiwari et al (2013) Mixed 1 PT = 0.15Δ♦ Small r
Within exposure
Quantity of Exposure Hedtke et al (2009) Mixed 1 PT = ⋄* – –
Benito et al (2018) OCD 2 PT = ⋄ – –





Time spent on Exposure Hedtke et al (2009)
Average length of exposure 
tasks per session
Mixed 1 PT = ⋄ – –
Benito et al (2018)
Duration of exposures
OCD 2 PT = ⋄ – –
Kircanski & Peris (2015)
Minutes spent on ERP 
tasks per session





Cumulative Dose of 
Exposure
Peris et al (2017) Mixed 1 PT = ⋄*** - -
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Table 3  (continued)
Construct Study Anxiety Type Studies (n) Effect Size by assessment 
timepoint
Cohen’s d or r
Percentage of Session with 
Exposure
Peris et al (2017) Mixed 1 PT = ⋄*** - -
Percentage of Session with 
Difficult Exposure
Peris et al (2017) Mixed 1 PT = ⋄*** - -
Proportion of Session with 
Combined Exposure





Frequency of Exposure 
Task Type
Hedtke et al (2009) Mixed 1 PT = ⋄ - -
Location of Exposure Task Hedtke et al (2009) Mixed 1 PT = ⋄ - -
Safety Seeking Hedtke et al (2009) Mixed 1 PT = -0.37Δ♦* Medium r
Cognitive Strategy Benito et al (2012) OCD 1 PT = ⋄ - -
Avoidance Statement 1 PT = ⋄ - -
Avoidant Behaviour 1 PT = ⋄ - -
Compliance Peris et al (2017) Mixed 1 PT = ⋄*** - -
Mastery Peris et al (2017) Mixed 1 PT = ⋄*** - -
Coping Hedtke et al (2009) Mixed 1 PT = 0.11Δ♦ Small r
Processing Hayes et al (2017) PTSD 2
Negative Emotion PT = 0.21♦ Small r
Avoidance PT = 0.00♦ NE r
Ruminative Processing PT = 0.06♦ NE r
Decentring PT = -0.02♦ NE r
Ready et al (2015)























Fear activation Hedtke et al (2009) Mixed 2 PT = ⋄ - -





Benito et al (2018) OCD 1 PT = ⋄ - -
Fear Reduction Peterman et al (2016) Mixed 2










Waters et al (2015) PT = 0.42Δ* Medium r
Benito et al (2018) OCD 2 PT = ⋄* – -










Variability of distress Waters et al (2015) Mixed 1 PT = 0.50Δ** Large r
Benito et al (2018) OCD 2 PT = ⋄ - -






Clinical Child and Family Psychology Review 
1 3
Table 3  (continued)
Construct Study Anxiety Type Studies (n) Effect Size by assessment 
timepoint
Cohen’s d or r
Expected minus actual 
distress










Parent involvement Hedtke et al (2009) Mixed 1 PT = ⋄ - -
Benito et al (2012)
Discourage avoidance


















Ost et al. (2001) PT = 0.25□
1y = 0.17□
BAT PT = ⋄







Therapist Involvement Benito et al (2012)
Discourage avoidance


















Child processing Tiwari et al (2013) Mixed 1 PT = 0.18Δ♦* Small r















Kircanski & Peris (2015) OCD 2 PT = ⋄
3 m = ⋄
– –
Kircanski, Wu and Piacen-
tini (2014)
PT = ⋄** – –
PaPT = ⋄*** – –
Homework Compliance Park et al (2014) OCD 1 PT = -0.65 Large r
Pa = parent report; PT = post-treatment; Follow-up: d = day, w = week, m = month, y = year; For between-subject studies (d): negative effect 
indicates lower anxiety level for “EXP plus” condition; positive effect indicates lower anxiety level for “EXP only/placebo” control condition; 
Δ = measure reported as change between assessment timepoints so that a higher score indicates a greater reduction in anxiety; ♦ = r imputed 
from β coefficients using Peterson and Brown’s (2005) imputation approach; □ = effect size calculated using available data; ⋄ = insufficient data 
available to calculate effect size; *p < .05, ** p < .01, *** p < .001; NE = did not meet the threshold for a small effect, BAT Behavioural Approach 
Test
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Exposure Characteristics and Optimisation 
Strategies
Before Exposure
Fourteen studies examined associations between pre-expo-
sure variables (administration of pharmacotherapy, model-
ling, attention training, social skills training and exposure 
preparation) and exposure outcomes.
Pharmacotherapy
D‑Cycloserine
Six studies examined the effect of DCS administration one 
hour prior to commencing exposure (Byrne et al. 2015; Far-
rell et al. 2013; Leyfer et al. 2019; Scheeringa and Weems 
2014; Storch et al. 2010, 2016), and two studies examined 
the effect of DCS administration at the beginning of each 
exposure session (Farrell et al. 2018; Rapee et al. 2016) All 
eight studies used a double blind, placebo-controlled design.
One study found a significant facilitative effect of DCS 
administered 1 hour before exposure on treatment outcomes 
(Byrne et al. 2015). In the treatment of specific phobias, 
Byrne et al. (2015) found that children and young adoles-
cents (aged 6–14 years) who received DCS administration 
prior to prolonged exposure did not perform significantly 
better than those who received a placebo control during a 
behaviour approach test (BAT) at 1-week follow-up, with a 
small effect size. However, when the stimulus was presented 
in a novel context (i.e. a different stimulus outdoors with 
no parent present) children who received DCS performed 
significantly better than those in the control group during 
the BAT, with a medium effect size. However, in a study 
which included children and adolescents (aged 8–18 years) 
with ‘difficult to treat’ OCD, Farrell et al. (2013) did not 
find a significant facilitative effect of DCS on OCD severity 
immediately post-treatment (did not meet a threshold for a 
small effect) nor at 1- and 3-month follow-up (medium and 
small effect size respectively). A large (though non-signif-
icant) facilitative effect of DCS was observed at 1-month 
follow-up, based on a parent report measure. In a third study, 
Storch et al. (2010) found that children and adolescents 
(aged 8–17 years) who received DCS before each of 7 ses-
sions of exposure did not have significantly greater improve-
ments in OCD severity immediately post-treatment com-
pared to those in a placebo condition, although the pattern 
of results suggested an advantage for DCS with a medium 
effect size. No significant differences were observed in the 
rate of improvement over time and no follow-up assessment 
was conducted. In a further study, Storch et al. (2016), found 
no significant difference in OCD severity for children and 
adolescents (aged 7–17 years) between those who received 
DCS and placebo control at post-treatment. Again, no fol-
low-up assessment was conducted.
One study focussed on the treatment of panic disorder 
in adolescents (aged 12–17 years) (Leyfer et al. 2019) and 
found no evidence for a significant facilitative effect of DCS 
on disorder severity at post-treatment, nor at 3-month fol-
low-up, compared to placebo control, with neither meeting 
the threshold for even a small effect.
One study focussed on the treatment of PTSD in children 
and adolescents (aged 7–18 years) (Scheeringa and Weems 
2014) and found no evidence of a significant facilitative 
effect of DCS taken one hour prior to narrative exposure, 
on PTSD symptoms at post-treatment or 3-month follow-up. 
However, the pattern of results indicated that children with 
high PTSD symptom scores who received the placebo, had 
lower symptoms both post-treatment and at 3-month follow-
up compared to those who received DCS, with a medium 
effect size.
Two studies involving children and young adolescents 
(7–14 years), with mixed anxiety disorders (Rapee et al. 
2016) and specific phobias (Farrell et al. 2018), examined 
the effect of DCS administered at the beginning of exposure. 
Findings from both studies suggested that DCS adminis-
tration at the beginning of exposure does not significantly 
enhance outcomes post-treatment. Specifically, in the treat-
ment of broad anxiety disorders, Rapee et al. (2016) found 
that those who received a placebo had (non-significantly) 
lower anxiety symptoms (based on child report) at post-treat-
ment than those who received DCS, with a medium effect. 
However, the opposite pattern was found with a parent report 
measure, in which those who received DCS had (non-sig-
nificantly) lower anxiety symptoms at post-treatment, with 
a small effect. In the treatment of specific phobias (Far-
rell et al. 2018), there were no significant benefits of DCS 
compared to placebo control in anxiety severity across any 
timepoints. However, when age was examined as a modera-
tor, significant differences were found between treatment 
conditions whereby improvements at post-treatment among 
the placebo group appeared to be accounted for by posi-
tive effects among adolescents, whereas improvements at 
the 1-month follow-up among the DCS group appeared to 
be accounted for by positive effects among pre-adolescent 
children.
Sertraline
Two studies examined the post-treatment effect of sertraline 
augmented exposure-based CBT for children and adoles-
cents aged 7–17 years with OCD (Storch et al. 2013; The 
Pediatric OCD Treatment Study (POTS) 2004). While POTS 
(2004) found a significant, facilitative effect of sertraline 
augmented treatment compared to CBT alone, with a small 
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effect size, the findings were not replicated by Storch et al. 
(2013) who did not find a significant difference in OCD 
severity between those who received sertraline (regular or 
slow dosing) and placebo control. The pattern of results 
indicated that children and adolescents who received the 
placebo, had lower OCD severity at post-treatment com-
pared to those who received slow sertraline dosing, with a 
small effect, but marginally greater OCD severity compared 
to those who received regular sertraline dosing, although 
neither effect was significant.
Attention Training to Positive Stimuli
One study compared the effects of a pre-treatment session in 
which children and adolescents (aged 6–17 years) received 
attention training to positive stimuli (i.e. modifying attention 
biases away from threatening, towards neutral, facial stimuli) 
or an attention training control, prior to a single session of 
exposure on outcomes for a specific phobia (Waters et al. 
2014). There were no significant between group differences 
at post-treatment nor 3-month follow-up (with only the post-
treatment results meeting the threshold for a small effect); 
however a greater post-treatment bias towards positive stim-
uli significantly predicted lower phobia severity at 3-month 
follow-up for children who received the pre-treatment atten-
tion training, with a small effect size.
Observational Learning
Two studies examined whether observational learn-
ing enhances exposure for children fearful of swimming 
(Menzies and Clarke 1993; Weiss et al. 1998). Weiss et al. 
(1998) allocated children (aged 5–7 years) to either in vivo 
exposure plus peer mastery modelling (PMM), peer cop-
ing modelling (PCM), or exposure alone (IVE). Children 
in the peer modelling groups either watched a video of a 
peer engage in highly competent (PMM) or less competent 
(PCM) swimming-related behaviour. Both mastery and cop-
ing modelling significantly enhanced exposure immediately 
post-exposure, both with a medium effect, but this was no 
longer significant by the 4-day follow-up, and effect sizes at 
this timepoint were small. A second study with 3 to 8-year-
old children found evidence that modelling may enhance 
in vivo exposure long term (Menzies and Clarke 1993). 
Children received either vicarious exposure (i.e. observed 
an adult swimming instructor model display competent, fear-
less behaviour while in a swimming pool) (IVVE) or a non-
related task (i.e. observed a variety of card games) (IVE) 
prior to 15 min of gradual in vivo exposure. There were no 
significant between group differences in fearful behaviour 
post-intervention or the extent to which treatment gains gen-
eralised to a novel swimming pool scenario; however, main-
tenance of fear reduction (i.e. approach-related behaviour) 
was significantly poorer from post- to 12-week follow-up in 
the IVE condition compared to the IVVE condition.
Social Skills Training
One study compared the effects of a pre-exposure social 
skills training by allocating adolescents (aged 14–17 years) 
with social anxiety disorder to receive either exposure-based 
CBT plus social skills training (e.g. starting/maintaining 
conversations, assertiveness, paying and accepting compli-
ments, making and keeping friends and training in public 
speaking), or exposure-based CBT alone (Olivares-Olivares 
et al. 2019). Compared to the CBT alone group, the CBT 
plus social skills training group had significantly greater 
improvements in the number of social situations feared and/
or avoided at post-treatment, 6- and 12-month follow-up, all 
with large effect sizes.
Exposure Preparation
In the treatment of children and young adolescents (aged 
7–13 years) with mixed anxiety disorders, Tiwari el al 
(2013) found that the amount of pre-exposure preparation 
(i.e. a broad, overall quality measure including activities 
such as an explanation of the rationale for exposure, select-
ing the exposure task, role-playing/practicing with the thera-
pist and discussion and/or selection of a reward) was not 
significantly related to anxiety severity immediately post-
treatment, with a small effect.
Within Exposure
Eleven studies examined associations between within-expo-
sure variables (features of exposure tasks, child factors, dis-
tress, parent and therapist involvement) and outcomes.
Features of Exposure Tasks
Four studies looked at associations between the characteris-
tics of exposure tasks and treatment outcomes (Benito et al. 
2018; Hedtke et al. 2009; Kircanski and Peris 2015; Peris 
et al. 2017).
Quantity of Exposure
Three studies examined the association between the amount 
of time spent on exposure and the number of exposures and 
treatment outcome for OCD (Benito et al. 2018; Kircanski 
and Peris 2015) and anxiety disorders (Hedtke et al. 2009). 
Notably, the studies differed in how the number of exposures 
were quantified. For example, Benito et al. (2018) measured 
the cumulative sum of all instances of fear change per par-
ticipant, whereas Hedtke et al. (2009) measured the total 
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number of exposure tasks per session. Nonetheless, the 
amount of time spent on exposure was not significantly asso-
ciated with better outcomes in any study (Benito et al. 2018; 
Hedtke et al. 2009; Kircanski and Peris 2015). Specifically, 
neither Benito et al. (2018) nor Kircanski and Peris (2015) 
found that number of exposures was significantly associ-
ated with better OCD outcomes (for children aged 7–17 and 
8–17 years respectively) at post-treatment or 3-month fol-
low-up (in Kircanski and Peris 2015). Furthermore, Hedtke 
et al. (2009) found that a greater number of exposure tasks 
per session was significantly associated with less change in 
anxiety severity from pre to post-treatment in the treatment 
of children and young adolescents (aged 7–13 years) with 
mixed anxiety disorders.
The amount of exposure has also been quantified based 
on the proportion of treatment that was spent on exposure 
in two studies (Peris et al. 2017; Kircanski and Peris 2015). 
Peris et al. (2017) found that for children and adolescents 
(aged 7–17 years) with mixed anxiety disorders, a greater 
percentage of sessions with exposure (therapist rated), and 
a greater “cumulative dose” of in vivo exposure, were both 
significantly associated with improved anxiety severity post-
treatment. There was also evidence that a greater propor-
tion of sessions containing exposures that the young person 
categorised as ‘difficult’ was significantly associated with 
improved anxiety severity post-treatment (Peris et al. 2017). 
Kircanski and Peris (2015) focussed specifically on the pro-
portion of combined exposures per session (i.e. single expo-
sure tasks that target more than one symptom or stimulus 
simultaneously) and found no evidence that the proportion 
of combined exposures was significantly associated with 
outcomes for children and adolescents (aged 7–18 years) 
with OCD post-treatment or at a 3-month follow-up.
Exposure Task Type
One study with 7–13-year-old children with mixed anxiety 
disorders (Hedtke et al. 2009), investigated the way in which 
the exposure was delivered (i.e. imaginal vs in vivo) and 
degree to which the exposure task matched the principal 
diagnosis, and found no evidence that either were signifi-
cantly associated with better outcomes post-treatment.
Location
There was no evidence that the location of exposure (i.e. 
imaginal or in vivo exposure occurring within or outside 
the therapy room) was significantly associated with treat-
ment outcomes, based on one study with children and young 
adolescents with mixed anxiety disorders (Hedtke et al. 
2009).
Child Factors
Three studies investigated the association between child 
behaviour during exposure and outcomes (Benito et al. 2012; 
Hedtke et al. 2009; Peris et al. 2017).
Safety Seeking and Avoidance
Two studies used video-taped exposure sessions to exam-
ine the relationship between child behaviours during expo-
sure and outcomes. Hedtke et al. (2009) found that safety 
seeking behaviour (e.g. checking for exits or bathrooms, 
carrying safety aids, hand sanitizer or repeatedly seeking 
verbal reassurance from others) during exposure was sig-
nificantly associated with less change in anxiety severity 
from pre to post-treatment, with a medium effect size. No 
follow-up assessments were conducted. In a second study, 
Benito et al. (2012) found that child avoidance statements 
(i.e. child statement indicating avoidance or distraction from 
exposure stimulus such as, “Is this going to hurt me?” and 
“Can I use the bathroom?”) and avoidance behaviours (e.g. 
avoiding contact with the exposure stimulus or using com-
pulsive behaviour) were not significantly associated with 
OCD severity at post-treatment or 3-month follow-up.
Cognitive Strategy
One study investigated children’s use of cognitive strate-
gies to try to lower anxiety (e.g. “I know I won’t actually 
hurt anyone because I’ve never done it before”) during 
exposure and found no significant association with OCD 
severity post-treatment or at 3-month follow-up (Benito 
et al. 2012).
Compliance, Mastery and Coping
Peris et al. (2017) found that therapist ratings (7-point scale) 
of child compliance (i.e. how well the child completed the 
requirements of therapy as specified by the therapist) and 
mastery (i.e. how well the child mastered the information/
skill presented during the session) within-exposure sessions 
were significantly associated with greater anxiety severity 
improvements at post-treatment for children and adolescents 
(7–17 years) with mixed anxiety disorders.
There was no evidence that child coping behaviour 
(i.e. behaviour that is used before or during exposure that 
is intended to help manage, not escape or avoid, anxiety 
or fear) during exposure was significantly associated with 
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changes in anxiety severity from pre to post-treatment and 
the effect was small (Hedtke et al. 2009).
Processing
Two studies with young people (7–17 years) with PTSD 
looked at associations between child processing during the 
narrative phase of treatment (i.e. exposure) and treatment 
outcomes (Hayes et al. 2017; Ready et al. 2015). Ready 
et al. (2015) found evidence that greater overgeneralisa-
tion (i.e. global, exaggerated beliefs of self, others, or the 
world related to a traumatic event) during exposure was sig-
nificantly associated with poorer PTSD symptom outcomes 
six months post-treatment, with a small effect size, but not 
immediately post-treatment or at 9-month or 12-month 
follow-up (with only post-treatment and 9-month follow-up 
meeting threshold for a small effect). There was no evidence 
that more accommodation (defined as the extent to which 
the individual shows a balanced view of the self, others, or 
the world) during exposure was significantly associated with 
short- or long-term outcomes (all but the 9-month follow-
up met the threshold for a small effect size). Reanalysis of 
data from the same trial found no evidence that unproduc-
tive processing (i.e. rumination and avoidance), productive 
processing (i.e. decentring) or levels of negative emotion 
expressed during exposure significantly predicted PTSD 
symptom outcomes, with only negative emotion meeting 
threshold for a small effect (Hayes et al. 2017).
Distress
Five studies investigated the relationship between child dis-
tress during exposure and treatment outcomes (Benito et al. 
2018; Hedtke et al. 2009; Kircanski and Peris 2015; Peter-
man et al. 2016; Waters et al. 2015).
Initial Distress
Kircanski and Peris (2015), found that initial distress (i.e. the 
SUDS level for the first exposure response prevention (ERP) 
task during the first ERP session) was not significantly asso-
ciated with OCD severity immediately post-treatment in 
children and adolescents (aged 8–17 years).
Fear Activation
Three studies examined the association between fear acti-
vation (i.e. the highest anxiety rating) during exposure and 
treatment outcomes (Benito et al. 2018; Hedtke et al. 2009; 
Peterman et al. 2016). None of the studies found signifi-
cant associations between fear activation and OCD or mixed 
anxiety symptom severity post-treatment (Benito et al. 2018; 
Hedtke et al. 2009; Peterman et al. 2016) and, in the one 
study where an effect size was available, this did reach a 
small effect at post-treatment and at 1-year follow-up (Peter-
man et al. 2016). However, secondary analysis of the data 
in Peterman et al. (2016) did find that greater initial fear 
activation was significantly associated with lower anxiety 
severity at 1-year follow-up for children with a diagnosis of 
separation anxiety and/or social anxiety disorder, but not for 
those with generalised anxiety disorder.
Fear Reduction
Four studies looked at the relationship between within-
exposure fear reduction and treatment outcomes (Benito 
et al. 2018; Kircanski and Peris 2015; Peterman et al. 2016; 
Waters et  al. 2015). There is mixed evidence from two 
studies with young people with OCD that greater within-
exposure fear reduction across treatment is associated with 
more positive outcomes. Benito et al. (2018) found that more 
‘habituation’ (which they operationalised as fear reduc-
tion at a time when no explicit strategies were applied to 
cope with/address fear) across a number of exposure ses-
sions (mean = 4) was associated with significantly greater 
reductions in OCD severity at post-treatment. There were 
no significant associations between peak-minus-end fear, 
(i.e. the end fear subtracted from the highest fear during 
the exposure), and the number of exposures ending with no 
fear across treatment and treatment outcomes. Kircanski and 
Peris (2015) found no significant association between the 
amount that distress decreased over the first three exposure 
tasks and OCD severity at post-treatment, nor at 3-month 
follow-up.
In the treatment of children and young adolescents (aged 
7–12 years) with mixed anxiety disorders, Waters et al. 
(2015) found that more within-session habituation across 
exposure sessions was associated with significantly greater 
improvements in anxiety severity at post-treatment, with a 
medium effect size. However, in the treatment of children 
and adolescents (aged 7–14 years), Peterman et al. (2016) 
found a small, non-significant relationship between within-
session habituation and anxiety severity at post-treatment, 
and 1-year follow-up.
50% Rule
In the treatment of children and young adolescents with 
mixed anxiety disorders, Peterman et al. (2016) found that 
greater use of the 50% rule (i.e. SUDS ratings reduction 
of at least 50% before ending the exposure task) was not 
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significantly related to anxiety severity at post-treatment 
or at 1-year follow-up, and this did not meet threshold for 
a small effect.
Variability of Distress
Three studies investigated emotional variability during 
exposure (Benito et al. 2018; Kircanski and Peris 2015; 
Waters et al. 2015). Notably, each study differed in terms 
of how emotional variability was measured; Benito et al. 
(2018) measured the cumulative sum of all observer rated 
fear increases and decreases throughout exposure, Kircanski 
and Peris (2015) calculated the average difference between 
the maximum and the minimum SUDS level for each ERP 
session, and Waters (2015) used the standard deviation of 
the four critical exposure SUDS ratings during each expo-
sure activity, averaged across 5 exposure activities. There is 
evidence from two studies that greater variability of distress 
during exposure is associated with better outcomes (Kircan-
ski and Peris 2015; Waters et al. 2015). At post-treatment, 
Waters et al. (2015) found a significant association between 
greater emotional variability and improved mixed anxiety 
severity immediately post-treatment, with a large effect 
size, although this association was not found by Benito et al. 
(2018) or Kircanski and Peris (2015). However, at 3-month 
follow-up, Kircanski and Peris (2015) did find that greater 
emotional variability in distress was significantly associated 
with reductions in OCD severity, with a medium effect size.
Differences between Expected and Actual Distress
In the treatment of children and adolescents with OCD, Kir-
canski and Peris (2015) found that the discrepancy between 
expected and actual distress, conceptualised as the average 
difference between anticipated distress and actual distress 
levels for each ERP session, was not significantly associated 
with improved OCD severity at immediate post-treatment, 
nor 3-month follow-up.
Final Distress
Kircanski and Peris (2015) found that final distress (i.e. the 
distress level for the final exposure task during the last expo-
sure session) was not significantly associated with improved 
OCD severity a post-treatment, or at a 3-month follow-up.
Therapist Involvement
One study investigated the association between therapist 
behaviour during exposure and OCD severity (Benito et al. 
2012). The study found that post-treatment, none of the 
following therapist behaviours were significantly associ-
ated with outcomes: addressing accommodation, encourag-
ing the use of cognitive strategies, unrelated talk, exposure 
comments, accommodation behaviour, externalising talk and 
discouraging avoidance. However, at the 3-month follow-
up, discouraging avoidance (i.e. discouraging the child from 
decreased mental or actual avoidance of exposure stimu-
lus, by statements such as “Keep looking at the sink”) was 
significantly associated with a greater reduction in OCD 
symptoms, with a very large effect size. No other significant 
associations were found.
Parent Involvement
Four studies looked at the association between parent 
involvement during exposure and outcomes (Benito et al. 
2012; Hedtke et al. 2009; Ollendick et al. 2015; Öst et al. 
2001).
In the treatment of childhood phobias, two studies com-
pared child-focussed one session exposure to parent aug-
mented exposure (Ollendick et al. 2015; Öst et al. 2001). In 
the study by Öst et al. (2001) parents were present during the 
session to function as a supportive figure and to be directly 
involved (e.g. modelling) where appropriate, whereas par-
ents in Ollendick et al. (2015) were provided with psych-
oeducation and taught strategies to reinforce courageous 
approach behaviours. Both of the studies found that children 
and adolescents aged 7–17 (Öst et al. 2001) and 6–15 years 
(Ollendick et al. 2015) who received parent augmented 
exposure did not significantly differ on reported fears and 
anxiety severity, respectively, at any timepoint from those 
who received child-focussed treatment alone (with small 
effects in favour of child only exposure at post-treatment for 
both studies, and at 6-month follow-up in Ollendick et al. 
2015). Notably, in the study by Öst et al. (2001), the child-
alone condition had significantly more clinically improved 
children and adolescents on a behavioural approach test 
(steps towards the feared animal, object or situation) at 
post-treatment compared to the parent augmented exposure 
group; however, no significant differences were found at 
1-year follow-up. There is no evidence that parent presence 
during exposure (i.e. whether at least one parent or guard-
ian was present during the planning or implementation of 
the exposure task) is associated with anxiety severity in the 
treatment of children and adolescents with mixed anxiety 
disorders (Hedtke et al. 2009). As for parent behaviours, 
Benito et al. (2012) found that none of 8 measured behav-
iours were associated with better outcomes in the short term 
but at 3-month follow-up, parent discouraging of avoidance 
was significantly associated with a greater reduction in OCD 
symptoms, with a very large effect size.
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Following Exposure
Five studies looked at the association between post-exposure 
characteristics (child processing, pharmacotherapy and fear 
reduction) and outcomes.
Child Processing
Tiwari et al. (2013) found that the child’s post-exposure 
processing (i.e. discussion of their experience and distress 
ratings) was significantly associated with greater improve-
ments in anxiety severity from pre to post-treatment, with a 
small effect size.
Pharmacotherapy
In a double blind, placebo-controlled study of adolescents 
(age 12–18 years) with OCD, Mataix-Cols et al. (2014) 
found that DCS administration immediately after exposure 
(sessions 3–12) did not significantly facilitate short or long-
term outcomes, and none of the associations met the thresh-
old for a small effect size.
Fear Reduction
Three studies examined whether greater between-session 
reduction of fear was associated with better treatment out-
comes (Kircanski and Peris 2015; Kircanski et al. 2014; 
Peterman et al. 2016). Results were inconsistent but notably 
studies differed in how between-session fear reduction was 
calculated. For example Kircanski et al. (2014), used the 
average child distress ratings for all obsessive compulsive 
symptoms per session, whereas Peterman et al. (2016) used 
the maximum child distress rating per session, to calculate 
differences between sessions. Kircanski et al. (2014) found 
a significant association between greater between-session 
reductions in both child and parent reported distress, and 
improved OCD severity outcomes at post-treatment. How-
ever, this finding was not replicated by Kircanski and Peris 
(2015) or Peterman et al. (2016) at post-treatment, 3-month 
or 1-year follow-up respectively. It is also important to note 
that, unlike Kircanski et al. (2015), Kircanski and Peris 
(2015) did not find a significant decrease in distress between 
sessions (e.g. as a result of exposures increasing in difficulty 
over the course of treatment) which may, in part, account for 
null findings.
Between Session
One study looked at the association among between-expo-
sure characteristics and outcomes.
Homework
In a reanalysis of data from a previous study (Storch et al. 
2010), Park et al. (2014) found a significant association 
between more homework compliance and greater reduc-
tions in OCD severity outcomes at post-treatment, with a 
large effect size.
Discussion
This review synthesised findings from 29 studies, examin-
ing factors associated with outcomes from exposure-based 
interventions in children and young people with anxiety 
symptoms/disorders. We found some preliminary evidence 
for specific optimisation strategies, such as dropping safety 
behaviours, parents and therapists discouraging avoidance, 
and the use of homework. However, not one significant find-
ing was replicated by another study for the same timepoint 
using the same methodology. To a large degree, this lack 
of replication reflects a lack of consistency across studies 
around conceptualisations, methodological approaches, and 
outcome measures, making it difficult to make meaningful 
comparisons between studies and limiting the scope for 
drawing meaningful, reliable conclusions.
Much of the literature used a habituation-based model to 
examine exposure characteristics and, in line with animal 
(Woods and Bouton 2008) and adult human (Craske et al. 
2008; Culver et al. 2012; Kircanski et al. 2012b) research, 
the studies generally failed to support a role of habituation-
based fear reduction in the successful treatment of child and 
adolescent anxiety disorders. For example, there was no evi-
dence of a significant association between treatment out-
come and initial fear activation (Benito et al. 2018; Hedtke 
et al. 2009; Peterman et al. 2016) or ‘the 50% rule’ (Peter-
man et al. 2016), and evidence was mixed for both within-
session fear reduction (Benito et al. 2018; Kircanski and 
Peris 2015; Peterman et al. 2016; Waters et al. 2015) and 
emotional variability during exposure (Benito et al. 2018; 
Kircanski and Peris 2015; Waters et al. 2015).
On the other hand, we found some evidence for the use of 
exposure strategies derived from inhibitory learning theory 
(e.g. Craske et al. 2008; Vervliet et al. 2013). Consistent with 
experimental research with adults (Salkovskis et al. 2007; 
Sloan and Telch 2002), reducing the young person’s use of 
safety behaviours and parents/therapists’ discouragement 
of avoidance during exposure (Benito et al. 2012; Hedtke 
et al. 2009) were significantly associated with enhanced 
outcomes. However, support for the use of pharmacological 
strategies to enhance memory consolidation was mixed (e.g. 
Byrne et al. 2015; Farrell et al. 2013; Scheeringa and Weems 
2014; Storch et al. 2010, 2016). Some studies found that 
characteristics that appeared to be consistent with inhibitory 
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learning strategies were associated with improved exposure 
outcomes, such as violation of expectancies (Tiwari et al. 
2013); however, the studies were not set up using this theo-
retical approach or terminology and therefore it is not clear 
whether the findings can truly be accounted for by inhibitory 
learning strategies.
Strengths and Limitations
This is the first systematic exploration of the current state 
of empirical literature on optimising exposure for child-
hood anxiety disorders. Strengths include the broad inclu-
sion criteria (e.g. all anxiety disorders/pre-existing fears, 
any anxiety outcome measure) and the use of a hierarchy 
of pre-specified outcome measures to determine selected 
outcomes. Where possible, effect sizes and quality ratings 
were considered in the interpretation of findings, particu-
larly where findings were mixed.
Nevertheless, the review only included up to two out-
come measures for each study therefore significant effects 
identified using different measures may have been over-
looked. There was wide variation in the quality of stud-
ies included, with lower quality studies failing to report 
on patient withdrawals from the study, compliance with 
the treatment, and therapist fidelity to treatment. In these 
instances, it is not possible to determine whether exposure 
strategies altered the amount of attrition from treatment or 
whether a lack of therapist fidelity or patient compliance 
may have washed out any potential effects. Crucially, the 
majority of studies did not report or adequately describe 
a power calculation and many studies lacked a sufficiently 
large sample size to detect potentially clinically meaning-
ful effects. Another key limitation is the small number of 
available studies and, within those, the extensive variation 
in the conceptualisation of key factors. That is, although 
several studies looked at similar constructs (e.g. within-
session reduction of fear, quantity of exposure), there 
was variation in how these constructs were measured. 
This resulted in mixed findings and limited comparability 
between studies. The majority of studies did not include 
a follow-up assessment, and of those that did; only seven 
(24%) included a follow-up beyond 3 months. Therefore, 
at this stage, inferences can only be based on short-term 
outcomes. Only one study examined age as a moderator 
(Farrell et al. 2018). Given that animal research (Ganella 
and Kim 2014; Kim and Richardson 2010) and threat-con-
ditioning studies with humans (Waters et al. 2017) sug-
gest that adolescence is a developmental period marked by 
impaired extinction learning relative to younger children 
and adults, further work is required to determine whether 
children and adolescents respond differently to strategies 
that target extinction mechanisms. The majority of key 
optimisation strategies identified within the adult literature 
(e.g. occasional reinforced extinction (Salkovskis et al. 
2007), stimulus variability (Culver et al. 2012; Kircanski 
et al. 2012b) and affect labelling (Kircanski et al. 2012a; 
Niles et al. 2015) have yet to be explored with children and 
young people, highlighting further gaps in the evidence 
base. Finally, there were a limited number of studies and 
many provided insufficient data to calculate an effect size 
or explore potential moderators of immediate treatment 
outcomes or the association between exposure strategies 
and outcomes, such as the amount of time spent on expo-
sure within treatment, how exposure was conducted (e.g. 
in vivo or imaginal), a focus on different disorders, or the 
amount or nature of parent involvement within treatment.
Clinical Implications
Given the lack of replication of findings, any implications 
for how exposure may be carried out to achieve the best 
clinical effects must be extremely tentative at this stage and 
further research is required to be able to make any strong 
recommendations. However, the preliminary findings sug-
gest that, during exposure, clinicians may find it beneficial to 
(i) ensure that the young person is engaged and able to mas-
ter the information and skills, (ii) focus on the reduction of 
safety behaviours, (iii) ensure that both they and the parent/
carer discourage the young person’s avoidance (iv) encour-
age the young person to do ‘difficult’ exposures within and 
between exposure sessions, (v) look for variable levels of 
fear within-exposure sessions such as greater emotional ups 
and downs, (vi) not try to do too many exposure exercises 
within the session (perhaps aiming for quality rather than 
quantity), and (vii) encourage the young person to discuss 
and process the experience following exposure.
Future Research Directions
An important first step in future research will be to develop 
and agree validated measures of potential exposure optimi-
sation variables that can be used within methodologically 
robust experimental and naturalistic studies. Future research 
should also address potential moderating factors; for exam-
ple, examining the effect of strategies among specific age 
groups especially in light of the existing animal research 
(Ganella and Kim 2014; Shechner et al. 2014) and different 
disorders (e.g. Peterman et al. 2016). Finally, the studies 
in this review predominantly included clinical samples. In 
line with adult research, it may be more efficient for future 
research to examine targeted, theoretically-driven strategies 
in methodologically robust, preclinical studies, and use the 
findings from these studies to guide and prioritise the devel-
opment of clinical research.
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Conclusion
Given that exposure appears to be the key ingredient in the 
treatment of anxiety disorders in children and young people 
(Ale et al. 2015; Kendall et al. 2005; Whiteside et al. 2015, 
2019), it is critical that we understand how best to deliver it 
to improve treatment outcomes. This review identified a lack 
of consistent support for any potential optimisation strate-
gies, wide ranging methodological inconsistencies among 
studies, and highlighted that most of the potential optimisa-
tion strategies identified within the adult literature have not 
been explored. Going forwards, future research should use 
consistent conceptualisations, methodological approaches, 
and outcome measures to enable meaningful comparisons 
between studies, examine other factors that have been found 
to facilitate exposure with adults, explore developmental dif-
ferences (for example, between children and adolescents), 
and look to expand the research field by robust examination 
of theoretically-driven potential optimisation strategies.
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